Literature DB >> 8217592

A cohort study of cystic fibrosis and malignancy.

C D Sheldon1, M E Hodson, L M Carpenter, A J Swerdlow.   

Abstract

A cohort of 412 patients first attending a cystic fibrosis (CF) clinic between 1961 and 1989 were followed up to 30 June 1989. The number of malignancies observed in the cohort was compared with the number expected based on the age, sex and calendar-year-specific cancer registration rates for England and Wales. Four CF patients were diagnosed as having malignancies before 30 June 1989. The tumours were: adenocarcinoma of the terminal ileum; adenocarcinoma of the pancreas, testicular teratoma, and B-cell lymphoma. This compares with 0.89 malignancies expected on the basis of rates in England and Wales (Standardised Registration Ratio = 452; 95% confidence interval 122-1150, P = 0.03). The single case of adenocarcinoma of the terminal ileum contrasts with less than 0.001 expected (P = 0.003) and that of the pancreas with 0.007 expected (P = 0.01). A further adenocarcinoma of the pancreas was diagnosed 2 years after the end of the study period. The two cases of pancreatic cancer compare with 0.008 expected (P = 0.0001) during the period to mid 1991. On the basis of the present findings and previous case reports in the literature adenocarcinoma of the pancreas and adenocarcinoma of the terminal ileum may be associated with cystic fibrosis.

Entities:  

Mesh:

Year:  1993        PMID: 8217592      PMCID: PMC1968740          DOI: 10.1038/bjc.1993.474

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Cystic fibrosis complicated by Hodgkin's lymphoma.

Authors:  R Marra; L Pagano; S Storti; S Valente; G Leone; B Bizzi
Journal:  Panminerva Med       Date:  1990 Jul-Sep       Impact factor: 5.197

2.  Childhood cancer and congenital defects. A study of U.S. death certificates during the period 1960-1966.

Authors:  R W Miller
Journal:  Pediatr Res       Date:  1969-09       Impact factor: 3.756

3.  Adenocarcinoma of the ileum presenting as non-traumatic clostridial myonecrosis in cystic fibrosis.

Authors:  A N Redington; R Spring; J C Batten
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

4.  Pancreatic carcinoma in a patient with cystic fibrosis.

Authors:  F J Tedesco; R Brown; B M Schuman
Journal:  Gastrointest Endosc       Date:  1986-02       Impact factor: 9.427

5.  Adenocarcinoma in cystic fibrosis.

Authors:  T M Davis; E H Sawicka
Journal:  Thorax       Date:  1985-03       Impact factor: 9.139

6.  Carcinoma of extrahepatic biliary system in an adult with cystic fibrosis.

Authors:  F W Abdul-Karim; T A King; B B Dahms; M W Gauderer; T F Boat
Journal:  Gastroenterology       Date:  1982-04       Impact factor: 22.682

7.  Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis.

Authors:  R C Stern; F C Rothstein; C F Doershuk
Journal:  J Pediatr Gastroenterol Nutr       Date:  1986-01       Impact factor: 2.839

8.  Small bowel mucosal dysfunction in patients with cystic fibrosis.

Authors:  C L Morin; C C Roy; R Lasalle; A Bonin
Journal:  J Pediatr       Date:  1976-02       Impact factor: 4.406

9.  Coeliac disease and malignancy.

Authors:  C M Swinson; G Slavin; E C Coles; C C Booth
Journal:  Lancet       Date:  1983-01-15       Impact factor: 79.321

10.  Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect.

Authors:  J D Fondacaro; J E Heubi; F W Kellogg
Journal:  Pediatr Res       Date:  1982-06       Impact factor: 3.756

View more
  19 in total

1.  Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis.

Authors:  M Srivastava; O Eidelman; H B Pollard
Journal:  Mol Med       Date:  1999-11       Impact factor: 6.354

2.  Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma.

Authors:  R McWilliams; W E Highsmith; K G Rabe; M de Andrade; L A Tordsen; L M Holtegaard; G M Petersen
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

Review 3.  Patterns of GI disease in adulthood associated with mutations in the CFTR gene.

Authors:  Michael Wilschanski; Peter R Durie
Journal:  Gut       Date:  2007-04-19       Impact factor: 23.059

4.  Detection of oncogenes in chronic pancreatitis.

Authors:  D Paramythiotis; J Kleeff; J Schmidt; M W Büchler; H Friess
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

Review 5.  Risk of pancreatic cancer in patients with cystic fibrosis.

Authors:  P Maisonneuve; B C Marshall; A B Lowenfels
Journal:  Gut       Date:  2007-09       Impact factor: 23.059

Review 6.  Subclinical colonic thickening.

Authors:  P J Oades; M Rosenthal; E J Mac Sweeney; A Bush
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

7.  Clostridium septicum Myonecrosis Secondary to an Occult Small Bowel Adenocarcinoma.

Authors:  Rachel N Saunders; Emiko Hayakawa; Charles J Gibson; Alistair J Chapman
Journal:  J Gastrointest Cancer       Date:  2019-12

8.  Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma.

Authors:  Robert R McWilliams; Gloria M Petersen; Kari G Rabe; Leonard M Holtegaard; Pamela J Lynch; Michele D Bishop; W Edward Highsmith
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

Review 9.  Cancer risk in patients with cystic fibrosis: the European data. CF/CSG Group.

Authors:  M H Schöni; P Maisonneuve; F Schöni-Affolter; A B Lowenfels
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

Review 10.  Emerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancers.

Authors:  Yuning Hou; Xiaoqing Guan; Zhe Yang; Chunying Li
Journal:  World J Gastrointest Oncol       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.